Abstract: A mobile shielded plot sprayer including a wind shield having a side wall that defines an enclosed area, and a movable atomizer within the enclosed area. A track assembly is located within the enclosed area and supported on the windshield. The atomizer is part of a spray assembly mounted on the track assembly and is movable thereon in at least one horizontal direction relative to the wind shield. A reservoir integral with the spray assembly and adapted to hold a liquid spray composition is operatively connected to the atomizer to supply the spray composition thereto.
Abstract: The present invention relates to cyclic sulfone moiety-containing hydroxyethylamine protease inhibitor compounds and pharmaceutical or method of use therefor, particularly as an inhibitor of HIV protease.
Abstract: The present invention is directed to a foldable, self-floating cover system for a body of water. This invention is also directed to a method of using this cover on a body of water, and particularly on a sewage lagoon to reduce the emission of offensive odors and/or gases.
Abstract: The invention includes selected novel optically active &agr;-amino ketones which either are themselves useful or are intermediates for the preparation of known ketomethylene pseudopeptides useful as antibiotics, antibiotic enhancers, or enzyme inhibitors. Further, the present invention provides a method for dehydrogenation/asymmetrical hydrogenation to obtain essentially pure antipodes of ketomethylene pseudopeptides having two chiral centers.
Abstract: N-heterocyclic moiety containing hydroxyethylamine compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
Type:
Application
Filed:
September 18, 2002
Publication date:
October 16, 2003
Applicant:
Monsanto Company
Inventors:
John J. Talley, Daniel P. Getman, Gary A. DeCrescenzo, Kathryn L. Reed, Ko-Chung Lin, John Nicholas Freskos, Michael Clare, Donald Joseph Rogier, Robert M. Heintz, Michael L. Vazquez, Richard A. Mueller
Abstract: A strategy for effecting virus resistance in plants causes the transcription in the plant cells of negative RNA strands which are substantially complementary to a target RNA strand. The target RNA strand can be an mRNA transcript created in gene expression, a viral RNA, or other RNA present in the plant cells. The negative RNA strand is complementary to at least a portion of the target RNA strand to inhibit its activity in vivo.
Type:
Grant
Filed:
October 16, 1985
Date of Patent:
September 9, 2003
Assignee:
Monsanto Company
Inventors:
Francis P. McCormick, Kenneth A. Barton, William F. Swain
Abstract: The present invention relates to a novel transformation system for generating transformed plants with lower copy inserts and improved transformation efficiency. In particular, the invention relates to the use of Agrobacterium growth inhibiting agents during the Agrobacterium-mediated transformation process that suppress Agrobacterium growth and reduce T-DNA transfer to the target plant genome.
Abstract: Polyvinyl butyral resin and sheet having a hydroxyl content less than 19.5, preferably about 17 to 19 weight %, calculated as polyvinyl alcohol, plasticized with a compatible amount of triethylene glycol di-2-ethylhexanoate.
Type:
Application
Filed:
January 22, 2003
Publication date:
July 31, 2003
Applicant:
Monsanto Company
Inventors:
John J. D'Errico, Berkeley A. Jemmott, Mary S. Krach, James R. Moran
Abstract: Improved methods for the identification of transgenic plants containing NPTII protein are disclosed. Application of organosilicone surfactant in combination with kanamycin and/or paromomycin facilitates the identification of plants containing NPTII protein.
Abstract: A concentrate package-mix composition comprising a water-soluble pesticide or plant growth regulator, for example a salt of the herbicide glyphosate, and a solid water-insoluble pesticide or plant growth regulator, for example the herbicide flumioxazin, is provided. The water-soluble pesticide or plant growth regulator is dissolved in a continuous aqueous phase of the composition and solid particles of the water-insoluble pesticide or plant growth regulator are suspended in the aqueous phase. These solid particles, individually or plurally, are intimately surrounded by a barrier layer, which comprises either one or both of a water-immiscible organic solvent or an emulsifying agent that has a hydrophile-lipophile balance (HLB) not greater than about 15. Optionally the composition further comprises a viscosity modifying agent, such as colloidal hydrophilic silica, dispersed in the aqueous phase.
Abstract: The utility of soybeans having a composition of greater than 40% of the protein as beta-conglycinin and less than 10% of the protein as glycinin for making highly functional high beta-conglycinin compositions was discovered. The discovered ingredients are useful for mimicking the texturizing properties of casein while also maintaining or improving physiological benefits of soy protein ingredients (e.g., cholesterol and triglyceride lowering properties). The high stability of the high beta-conglycinin compositions against protein—protein aggregation reactions is valuable for creating good tasting beverages and beverage mixes. Cheese with good spreadability, gloss and smoothness was made using an enzyme-modified version of the new ingredient composition. Cheese with good firmness and meltability was also created using a different enzyme-treatment. High beta-conglycinin compositions were found to demonstrate excellent emulsifying and gelling properties in the pH region (5.5-6.
Abstract: Polyvinyl butyral resin and sheet having a hydroxyl content less than 19.5, preferably about 17 to 19 weight %, calculated as polyvinyl alcohol, plasticized with a compatible amount of triethylene glycol di-2-ethylhexanoate.
Type:
Grant
Filed:
December 29, 1995
Date of Patent:
May 6, 2003
Assignee:
Monsanto Company
Inventors:
John J. D'Errico, Berkeley A. Jemmott, Mary S. Krach, James R. Moran
Abstract: This invention is directed to a process for making an iminodiacetic acid compound from a monoethanolamine substrate having the formula:
wherein R1 is hydrogen, hydrocarbyl, or substituted hydrocarbyl. The process includes a series of reactions comprising a cyanomethylation, a hydrolysis and a dehydrogenation with the hydrolysis and dehydrogenation steps being carried out either sequentially or concurrently. In a particular embodiment, the iminodiacetic acid produced is disodium iminodiacetic acid and the monoethanolamine substrate used is 2-aminoethanol.
Type:
Grant
Filed:
May 15, 2001
Date of Patent:
April 29, 2003
Assignee:
Monsanto Company
Inventors:
Howard C. Berk, Thaddeus S. Franczyk, II, Robert B. Weisenfeld, David A. Morgenstern, Juan P. Arhancet, William L. Moench, James C. Peterson
Abstract: The present invention relates to cyclic sulfone moiety-containing hydroxyethylamine protease inhibitor compounds and pharmaceutical or method of use therefor, particularly as an inhibitor of HIV protease.
Type:
Grant
Filed:
October 11, 2001
Date of Patent:
April 22, 2003
Assignee:
Monsanto Company
Inventors:
Deborah E. Bertenshaw, Daniel Getman, Robert M. Heintz, John J. Talley, Kathryn L. Reed, Robert Alan Chrusciel, Michael Clare
Abstract: The invention includes selected novel optically active &agr;-amino ketones which either are themselves useful or are intermediates for the preparation of known ketomethylene pseudopeptides useful as antibiotics, antibiotic enhancers, or enzyme inhibitors. Further, the present invention provides a method for dehydrogenation/asymmetrical hydrogenation to obtain essentially pure antipodes of ketomethylene pseudopeptides having two chiral centers.
Abstract: N-heterocyclic moiety containing hydroxyethylamine compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
Type:
Grant
Filed:
October 31, 2000
Date of Patent:
January 14, 2003
Assignee:
Monsanto Company
Inventors:
John J. Talley, Daniel P. Getman, Gary A. DeCrescenzo, Kathryn L. Reed, Ko-Chung Lin, John Nicholas Freskos, Michael Clare, Donald Joseph Rogier, Jr., Robert M. Heintz, Michael L. Vazquez, Richard A. Mueller
Abstract: The invention provides a method for analyzing spatial variations in field and crop performance. The method allows analysis of the field and crop performance as a function of various treatment and/or environmental conditions. This method is an advance over the prior art in that it allows better defined, more accurate comparisons of adjacent test areas, eliminating the need for extrapolation of data and avoiding inaccuracies therefrom. Also, the more accurate comparisons allow better characterization of effects due to the environment, such as those caused by genotype by environment (G×E) interaction. The more accurately defined comparison units also lead to improved analysis when comparing to other data layers for non-spatial analysis. The invention also provides a system for carrying out this method. The system preferably includes a device for inputting spatially-referenced data, a memory, an output device, and a processor. The output data may be represented spatially or non-spatially.
Abstract: The present invention is in the field of soybean genetics. More specifically, the invention relates to nucleic acid molecules from regions the soybean genome, which are associated with soybean cyst nematode resistance. The invention also relates to proteins encoded by such nucleic acid molecules as well as antibodies capable of recognizing these proteins. The invention also relates to nucleic acid markers from regions the soybean genome, which are associated with soybean cyst nematode resistance. Moreover, the invention relates to uses of such molecules, including, transforming soybean cyst nematode resistant soybean with constructs containing nucleic acid molecules from regions the soybean genome, which are associated with soybean cyst nematode resistance. Furthermore, the invention relates to the use of such molecules in a plant breeding program.
Type:
Application
Filed:
January 5, 2001
Publication date:
January 2, 2003
Applicant:
Monsanto Company
Inventors:
Brian M. Hauge, Ming Li Wang, Jeremy David Parsons, Laurence David Parnell
Abstract: The present invention provides a method for inhibiting the activity of cyclooxygenase-2 and other proinflammatory factors in a mammal. The method comprises administering to the mammal, a therapeutically effective or prophylactically effective amount of an organic extract of Atractylodes lancea. The inhibitory effect of the organic extract of this invention on cyclooxygenase-2 activity is substantially greater than the inhibitory effect of the organic extract on cyclooxygenase-1 activity. The present invention also provides a method for treating a mammal having, or at risk for developing, a condition which is benefited by the inhibition of cyclooxygenase-2 or other proinflammatory factors. The method comprises administering to the mammal a therapeutically effective or prophylactically effective amount of the organic extract of Atractylodes lancea.
Abstract: A tablet coating useful for coating an active selected from the group consisting of aspirin, ibuprofen, naproxin sodium, acetaminophen, celecoxib, sildenafil citrate, alendronate sodium, an analgesic in combination with one or more of an antitussive, antihistamine, decongestant and expectorant, oxaprozin, comprising gellan gum along with a process which comprises admixing gellan gum and water under effective shear conditions to prepare an aqueous gellan gum coating composition thereof whereby the aqueous gellan gum coating composition is applied in an adherent fashion to a placebo or a tablet containing an active to form a gellan gum coated placebo or gellan gum coated active.
Type:
Grant
Filed:
October 11, 1999
Date of Patent:
November 26, 2002
Assignee:
Monsanto Company
Inventors:
John Flanagan, Terry L. Smith, Aaron Barkley, Richard E. Nicholson, Timothy Patrick Callahan